
Areas of Expertise
Conditions I Treat
- Ovarian cancers and conditions
- Uterine cancers and conditions
- Cervical cancers and conditions
Get to Know Me
I am a medical oncologist who focuses on the medical treatment of gynecologic cancers. I also have a research interest in developing improved therapies for endometrial cancer.
A gynecologic (GY-neh-kuh-LAH-jik) medical oncologist is a cancer doctor who specializes in gynecologic cancers. This includes cervical, fallopian tube, ovarian, uterine (endometrial), vaginal, and vulvar cancers.
- Section Head, Endometrial Cancer Program
- Director, Hematology-Medical Oncology Fellowship Training Program
- Associate Attending Physician
Conditions I Treat
- Ovarian cancers and conditions
- Uterine cancers and conditions
- Cervical cancers and conditions
Education
- MD, University of Florida College of Medicine
Residencies
- Internal Medicine - Beth Israel Deaconess Medical Center
Fellowships
- Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment

Contact and Location
Dr. Makker sees patients at one location.












Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Makker
- A Phase 1 Study of CLN-619 Alone and With Pembrolizumab Immunotherapy in People With Advanced Cervical or Endometrial Cancer
- A Phase 2 Study of Datopotamab Deruxtecan Alone or With Other Anti-Cancer Drugs in People Endometrial, Ovarian, and Urothelial Cancers
- A Phase I/II Study of MORAb-202 in People with Endometrial or Ovarian Cancer
- A Phase I/IIA Study of DB-1303 in People with Advanced Endometrial Cancer or Endometrial Carcinosarcoma
Read more
- A Phase II Study of Pembrolizumab Immunotherapy with Lenvatinib in Women with Advanced Uterine Carcinosarcoma
- A Phase II Study of Trastuzumab Deruxtecan in People with HER2-Positive Solid Tumors
- Clinical Trials Co-Investigated by Dr. Makker
- A Phase 1 Study of DB-1305 in People with Advanced Ovarian, Endometrial, Cervical, or Lung Cancers
- A Phase 2 Study of Nab-sirolimus and Letrozole in People With Endometrial Cancer
- A Phase II Study of Ado-Trastuzumab Emtansine in Patients with Cancers Driven by HER2

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
4.9 142 reviews
- 4.9 Provider's Explanations Easy to Understand
- 5.0 Trusts Provider with Care
- 4.9 Provider Listened Carefully
- 4.9 Likelihood of Recommending Provider
The experience was excellent in every way. Dr. Makker, as well as the entire staff, was so caring and patient with me. All of my questions were answered in a way that I could understand. I feel very confident that I am in the best possible place.
First time meeting Dr. Makker, and I am so grateful to have her on my care team. I'm really excited to work with her.
I want to note that I waited three and a half hours past my scheduled follow-up appointment time for my test results. This was due to a delay from radiology, it was not my provider's fault. Please note that is it very stressful to have to sit that long on the 6th floor of MSK at 160 East 53rd Street and wait. I had to ask to receive clear information about the delay. I feel my follow-up was scheduled too close to my scan time, and that was part of the problem. But it was a very long and tough day, seven hours total from arrival to and departure from MSK.
Ruth is outstanding - she understood my requirement and helped me get an appointment with Dr Makker asap. Uwa and Ruth make a great team! Dr Makker is amazing - besides being an expert she is so patient and caring. I am so glad to be under her care.
The most positive visit. I debated getting a small apt. In NYC so Dr Makker could treat me! The plan she said was best can be implemented locally at our Norton Cancer Center in KY. All my family, 3 daughters, 2 sons in law, and two grandsons live in Louisville. She was thorough, knowledgeable, do intelligent and the most remarkable person I've ever met. Highly recommend going to MSKCC for a 2nd opinion or treatment... it's top notch
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Vicky Makker discloses the following relationships and financial interests:
-
ArQule
Professional Services and Activities (Uncompensated) -
AstraZeneca
Professional Services and Activities (Uncompensated) -
Clovis Oncology
Professional Services and Activities (Uncompensated) -
Cullinan Oncology, Inc.
Professional Services and Activities (Uncompensated) -
Duality Biologics
Professional Services and Activities (Uncompensated) -
Eisai
Professional Services and Activities -
Faeth Therapeutics, Inc
Professional Services and Activities (Uncompensated) -
GlaxoSmithKline
Professional Services and Activities (Uncompensated) -
IBM
Professional Services and Activities -
Immunocore
Professional Services and Activities (Uncompensated)
-
Iteos Therapeutics
Professional Services and Activities (Uncompensated) -
Jazz Pharmaceuticals
Professional Services and Activities (Uncompensated) -
Kartos Therapeutics, Inc.
Professional Services and Activities (Uncompensated) -
Karyopharm
Professional Services and Activities -
Merck & Co Inc.
Professional Services and Activities -
Mereo BioPharma
Professional Services and Activities (Uncompensated) -
MorphoSys AG
Professional Services and Activities (Uncompensated) -
Novartis
Professional Services and Activities (Uncompensated) -
Zymeworks Inc.
Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.